Show summary Hide summary
A widely used supplement now faces scrutiny after a new five-year study linked regular omega-3 pill use to quicker drops in thinking skills among older adults. The work challenges the common belief that fish oil or concentrated omega-3s uniformly protect the aging brain.
How researchers followed older adults over time
Scientists in China monitored more than 800 seniors for five years. Participants took repeated cognitive tests and underwent brain imaging.
Eggs every day for months: simple check reveals shocking blood test result
Popular childhood food ingredient may raise adult anxiety: study
- Total participants: over 800 older adults.
- Supplement users: 273 people who reported taking omega-3 capsules.
- Non-users: 546 people who did not take the supplements.
- Duration: five years with serial testing and scans.
Findings that surprised investigators
After adjusting for age, sex, genetic risk and diagnosis, people taking omega-3 pills showed steeper declines on three different cognitive tests.
The pattern held regardless of APOE ε4 status. About half of participants in each group carried that gene variant linked to higher Alzheimer’s risk.
Brain scans revealed a metabolic change
Imaging did not point to higher amyloid plaque or tau tangle burden in supplement users.
Instead, scans detected a notable fall in brain glucose metabolism among those taking omega-3 capsules. That suggests neurons were less efficient at using sugar for fuel.
Possible biological explanations
Researchers offered a mechanistic clue: supplements may impair synaptic signaling by altering how brain cells process energy.
- Disrupted glucose use could weaken communication across synapses.
- Reduced synaptic efficiency may hasten cognitive decline before structural damage appears.
- The result is a change in function, not necessarily classic Alzheimer pathology.
Study strengths and important limitations
The team highlighted that this was an observational study. That means it shows association, not proof of cause.
- Strengths: repeated tests and imaging over multiple years.
- Limitations: self-reported supplement use and no randomized assignment.
- Open questions remain about dose, formulation and duration of use.
How this fits with prior research on omega-3s
Past studies on omega-3s and cognition have produced mixed results. Some found benefits, others found little or none.
Experts note a possible difference between whole-food sources and isolated capsules. Foods like salmon deliver omega-3s plus other nutrients that may work together.
Numbers that matter for public health
Fish oil remains popular: roughly one in five Americans over 60 report taking fish oil daily, according to a 2023 report.
At the same time, cognitive impairment is already widespread. Nearly one-third of people 65 and older show some level of decline in thinking skills, and about 10% have dementia.
Projections suggest the burden will grow. A 2025 analysis estimated the US could see about 1 million new dementia cases annually by 2060.
What scientists recommend next
Authors of the study urged caution and further investigation. They wrote that the findings “challenge the prevailing view” of omega-3s as uniformly protective.
- Researchers call for randomized trials to test causality.
- They recommend more work on how different formulations affect brain metabolism.
- Investigations should also compare supplements with whole-food omega-3 sources.
